Patient Characteristics at Baseline
myalgia, fatigue, infections, pain, rashes
ONCOLOGY, ADVERSE EVENT, INJECTION SITE REACTION, INFECTIONS
Abbreviation: ECOG, Eastern Cooperative Oncology Group.Data are presented as number (percentage) of patients unless otherwise indicated.Seven patients (58%) had at least a grade 1 adverse event (AE), with only 1 patient (8%) in the 5-μg cohort having grade 2 AEs (myalgia and fatigue). The most common AE reported was fatigue in 5 patients (42%), followed by injection site reaction (2 [17%]); all injection site reactions were pain related. No serious infections or rashes were reported. There was no association between the dose of IT GLA-SE and the frequency or severity of AEs (